Global Combined hormonal contraceptive Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 95

Report ID: 12559

Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.
The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.

The global Combined hormonal contraceptive market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Combined hormonal contraceptive volume and value at global level, regional level and company level. From a global perspective, this report represents overall Combined hormonal contraceptive market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Pills
Patch
Ring

Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others

Table of Contents

Executive Summary
1 Combined hormonal contraceptive Market Overview
1.1 Product Overview and Scope of Combined hormonal contraceptive
1.2 Combined hormonal contraceptive Segment by Type
1.2.1 Global Combined hormonal contraceptive Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Pills
1.2.3 Patch
1.2.4 Ring
1.3 Combined hormonal contraceptive Segment by Application
1.3.1 Combined hormonal contraceptive Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.3.5 Others
1.4 Global Combined hormonal contraceptive Market by Region
1.4.1 Global Combined hormonal contraceptive Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Combined hormonal contraceptive Market Size
1.5.1 Global Combined hormonal contraceptive Revenue (2014-2025)
1.5.2 Global Combined hormonal contraceptive Production (2014-2025)

2 Global Combined hormonal contraceptive Market Competition by Manufacturers
2.1 Global Combined hormonal contraceptive Production Market Share by Manufacturers (2014-2019)
2.2 Global Combined hormonal contraceptive Revenue Share by Manufacturers (2014-2019)
2.3 Global Combined hormonal contraceptive Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Combined hormonal contraceptive Production Sites, Area Served, Product Types
2.5 Combined hormonal contraceptive Market Competitive Situation and Trends
2.5.1 Combined hormonal contraceptive Market Concentration Rate
2.5.2 Combined hormonal contraceptive Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Combined hormonal contraceptive Production Market Share by Regions
3.1 Global Combined hormonal contraceptive Production Market Share by Regions
3.2 Global Combined hormonal contraceptive Revenue Market Share by Regions (2014-2019)
3.3 Global Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Combined hormonal contraceptive Production
3.4.1 North America Combined hormonal contraceptive Production Growth Rate (2014-2019)
3.4.2 North America Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Combined hormonal contraceptive Production
3.5.1 Europe Combined hormonal contraceptive Production Growth Rate (2014-2019)
3.5.2 Europe Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Combined hormonal contraceptive Production (2014-2019)
3.6.1 China Combined hormonal contraceptive Production Growth Rate (2014-2019)
3.6.2 China Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Combined hormonal contraceptive Production (2014-2019)
3.7.1 Japan Combined hormonal contraceptive Production Growth Rate (2014-2019)
3.7.2 Japan Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Combined hormonal contraceptive Consumption by Regions
4.1 Global Combined hormonal contraceptive Consumption by Regions
4.2 North America Combined hormonal contraceptive Consumption (2014-2019)
4.3 Europe Combined hormonal contraceptive Consumption (2014-2019)
4.4 China Combined hormonal contraceptive Consumption (2014-2019)
4.5 Japan Combined hormonal contraceptive Consumption (2014-2019)

5 Global Combined hormonal contraceptive Production, Revenue, Price Trend by Type
5.1 Global Combined hormonal contraceptive Production Market Share by Type (2014-2019)
5.2 Global Combined hormonal contraceptive Revenue Market Share by Type (2014-2019)
5.3 Global Combined hormonal contraceptive Price by Type (2014-2019)
5.4 Global Combined hormonal contraceptive Production Growth by Type (2014-2019)

6 Global Combined hormonal contraceptive Market Analysis by Applications
6.1 Global Combined hormonal contraceptive Consumption Market Share by Application (2014-2019)
6.2 Global Combined hormonal contraceptive Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Combined hormonal contraceptive Business
7.1 Teva Pharmaceutical Industries
7.1.1 Teva Pharmaceutical Industries Combined hormonal contraceptive Production Sites and Area Served
7.1.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.1.3 Teva Pharmaceutical Industries Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Bayer HealthCare Pharmaceuticals
7.2.1 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Production Sites and Area Served
7.2.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.2.3 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Actavis
7.3.1 Actavis Combined hormonal contraceptive Production Sites and Area Served
7.3.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.3.3 Actavis Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Pfizer
7.4.1 Pfizer Combined hormonal contraceptive Production Sites and Area Served
7.4.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.4.3 Pfizer Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Combined hormonal contraceptive Production Sites and Area Served
7.5.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.5.3 Johnson & Johnson Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Combined hormonal contraceptive Production Sites and Area Served
7.6.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.6.3 GlaxoSmithKline Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Watson Pharma
7.7.1 Watson Pharma Combined hormonal contraceptive Production Sites and Area Served
7.7.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.7.3 Watson Pharma Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Cipla
7.8.1 Cipla Combined hormonal contraceptive Production Sites and Area Served
7.8.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.8.3 Cipla Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Novartis International
7.9.1 Novartis International Combined hormonal contraceptive Production Sites and Area Served
7.9.2 Combined hormonal contraceptive Product Introduction, Application and Specification
7.9.3 Novartis International Combined hormonal contraceptive Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served

8 Combined hormonal contraceptive Manufacturing Cost Analysis
8.1 Combined hormonal contraceptive Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Combined hormonal contraceptive
8.4 Combined hormonal contraceptive Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Combined hormonal contraceptive Distributors List
9.3 Combined hormonal contraceptive Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Combined hormonal contraceptive Market Forecast
11.1 Global Combined hormonal contraceptive Production, Revenue Forecast
11.1.1 Global Combined hormonal contraceptive Production Growth Rate Forecast (2019-2025)
11.1.2 Global Combined hormonal contraceptive Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Combined hormonal contraceptive Price and Trend Forecast (2019-2025)
11.2 Global Combined hormonal contraceptive Production Forecast by Regions (2019-2025)
11.2.1 North America Combined hormonal contraceptive Production, Revenue Forecast (2019-2025)
11.2.2 Europe Combined hormonal contraceptive Production, Revenue Forecast (2019-2025)
11.2.3 China Combined hormonal contraceptive Production, Revenue Forecast (2019-2025)
11.2.4 Japan Combined hormonal contraceptive Production, Revenue Forecast (2019-2025)
11.3 Global Combined hormonal contraceptive Consumption Forecast by Regions (2019-2025)
11.3.1 North America Combined hormonal contraceptive Consumption Forecast (2019-2025)
11.3.2 Europe Combined hormonal contraceptive Consumption Forecast (2019-2025)
11.3.3 China Combined hormonal contraceptive Consumption Forecast (2019-2025)
11.3.4 Japan Combined hormonal contraceptive Consumption Forecast (2019-2025)
11.4 Global Combined hormonal contraceptive Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Combined hormonal contraceptive Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer